Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Response to Naltrexone for Alcohol Dependence

NCT00831272 is registered in ClinicalTrials.gov with David Oslin as lead sponsor.

NCT NCT00831272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00831272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Response to Naltrexone for Alcohol Dependence
Lead sponsor
David Oslin
Phase
Phase 4
Overall status
Completed
Start date
January 5, 2009
Completion date
January 15, 2014
Enrollment
221 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence